Sign in
4

Changes in Ownership

Aurinia Pharmaceuticals Inc. Filed Acc 0001628280-22-005130

Chief Business Officer sold 4,849 shares at $12.01 ($58,236)

  • Chief Business Officer acquired 8,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Martin Michael Robert · Chief Business Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2022-03-02 Grant or award : show line 1 in the form +8,500 64,361 D
2022-03-02 Sale : show line 2 in the form −4,849 $12.01 $58,236 59,512 D
Open-market sales · 4,849 sh · avg $12.01 · $58,236

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2022-03-02 Grant or award : show line 3 in the form Restricted Stock Unit +62,448 62,448 D
2022-03-02 Grant or award : show line 4 in the form Stock Option (right to buy) +106,838 106,838 D
Loading xslF345X03/wf-form4_164642837303389.xml…